Skin diseases are the fourth leading cause of disability worldwide, affecting billions of people across all ages. The Global Burden of Disease project ranks the top 10 skin conditions by their overall health impact, measured in years of healthy life lost. In order, they are: dermatitis, acne, psoriasis, urticaria (hives), viral skin diseases, fungal skin diseases, scabies, melanoma, pyoderma, and cellulitis. Here’s what each one actually looks like, who it affects, and how it’s managed.
Dermatitis
Dermatitis is the single largest contributor to the global skin disease burden, accounting for about 22% of all skin-related disability. The term covers several conditions, but the two most common forms are atopic dermatitis (eczema) and contact dermatitis.
Atopic dermatitis causes patches of dry, intensely itchy skin that tend to flare and then partially clear. A 2024 global study found it affects roughly 10% of people aged 16 and older, with adult rates ranging from 3% to 10% depending on the country. In children, it typically shows up in the creases of the elbows and behind the knees. Adults often see it on the hands, face, and neck. The condition is closely tied to allergic tendencies, and people with it frequently have elevated levels of the immune protein IgE.
Contact dermatitis, by contrast, happens when something you touch triggers a reaction. Patch testing data consistently identifies nickel as the most common culprit (about 24% of cases), followed by cobalt, balsam of Peru (found in many shampoos and conditioners), fragrance mixes, and rubber compounds. If you notice a rash that lines up with where jewelry, cosmetics, or cleaning products touch your skin, contact dermatitis is a likely explanation.
Acne
Acne ranks second globally, representing about 17% of the skin disease burden. It develops when oil glands in the skin overproduce sebum, dead skin cells clog the follicle, and bacteria multiply inside the blocked pore, triggering inflammation. Hormonal shifts during puberty, menstruation, and stress all ramp up oil production.
Mild to moderate acne, meaning mostly blackheads, whiteheads, and scattered red bumps, is typically treated with topical creams that speed skin cell turnover and keep pores clear. For moderate to severe cases with deeper, painful nodules or scarring, oral medications that reduce oil production from the inside are the standard approach. The key factor that determines treatment isn’t just how many pimples you have but whether scarring is occurring, because scars are permanent and warrant more aggressive early treatment.
Psoriasis
Psoriasis and urticaria are tied for third place, each contributing about 11% of skin-related disability. Plaque psoriasis accounts for 80% to 90% of cases and is recognizable by well-defined, raised red patches covered in silvery-white scales. It commonly appears on the elbows, knees, scalp, and lower back, though it can develop anywhere.
Unlike eczema, which tends to create poorly defined, weepy patches, psoriasis plaques have sharp borders and thick, dry scales. The two conditions can look similar at a glance, since both cause redness, scaling, and itching, but psoriasis is driven by an overactive immune response that causes skin cells to multiply roughly ten times faster than normal. Treatment for mild psoriasis usually involves medicated creams, while moderate to severe cases increasingly rely on injectable medications that target specific immune signals fueling the overproduction. These newer therapies have dramatically improved outcomes for people with widespread disease.
Urticaria (Hives)
Hives are raised, itchy welts that can appear anywhere on the body and typically shift location within hours. When episodes last fewer than six weeks, they’re considered acute and are usually triggered by an allergic reaction, infection, or medication. Chronic hives persist for six weeks or longer, and in most cases no external cause is ever identified.
Chronic spontaneous urticaria appears to have an autoimmune basis in many people, meaning the immune system mistakenly activates the skin cells that release histamine. It commonly coexists with other autoimmune conditions, including thyroid disease, celiac disease, and type 1 diabetes. The condition is self-limiting, which means it eventually resolves on its own, but that process can take months to years. Routine extensive allergy testing is generally unnecessary because most chronic cases have no identifiable external trigger.
Viral Skin Diseases
This category covers warts (caused by human papillomavirus), cold sores (herpes simplex), shingles (varicella-zoster reactivation), and molluscum contagiosum. Together, viral skin conditions account for about 9% of the global skin disease burden. Warts are by far the most common, especially in children and young adults, and most resolve without treatment within one to two years as the immune system clears the virus. Shingles is notable because it affects roughly one in three people over a lifetime and can leave lasting nerve pain even after the rash heals.
Fungal Skin Diseases
Fungal infections contribute about 9% of skin-related disability. Athlete’s foot is the most familiar example, affecting roughly 10% of the global population. One species of fungus, Trichophyton rubrum, is responsible for about 70% of cases. Ringworm (which is a fungus, not a worm) creates the classic expanding red ring on the trunk or limbs, while jock itch targets the groin folds.
These infections thrive in warm, moist environments. Shared showers, locker rooms, and tight-fitting shoes are common sources. Most cases respond well to over-the-counter antifungal creams applied for two to four weeks, though fungal nail infections can take months of treatment.
Scabies
Scabies is caused by a microscopic mite that burrows into the top layer of skin, laying eggs and triggering intense itching that’s typically worse at night. It accounts for about 4% of the global skin disease burden and is most prevalent in crowded living conditions and tropical regions. The rash often appears as tiny raised lines or bumps between the fingers, on the wrists, and around the waistline. Scabies spreads through prolonged skin-to-skin contact and is treated with prescription creams that kill the mites, though itching can persist for several weeks after successful treatment because the immune reaction takes time to settle.
Melanoma
Melanoma ranks eighth in overall skin disease burden but is disproportionately important because it is the deadliest form of skin cancer. It develops in the pigment-producing cells of the skin and can spread to other organs if not caught early. However, melanoma is far less common than the other skin cancers. Basal cell carcinoma is the most frequently diagnosed skin cancer, with an estimated 3.6 million cases per year in the U.S. alone. Squamous cell carcinoma follows at roughly 1.8 million annual U.S. cases.
What sets melanoma apart is its mortality risk. The ABCDE rule remains the most practical self-screening tool: look for moles that are Asymmetric, have irregular Borders, uneven Color, a Diameter larger than a pencil eraser, or are Evolving in size, shape, or color. UV exposure, both from sunlight and tanning beds, is the primary preventable risk factor across all three skin cancer types.
Pyoderma
Pyoderma is a bacterial skin infection, most commonly caused by staph or strep bacteria. It includes impetigo (the honey-crusted sores frequently seen on children’s faces), boils, and deeper tissue infections. It contributes about 3% of the global skin disease burden. Impetigo spreads easily in daycare and school settings through direct contact or shared towels. Most superficial cases clear with topical antibiotics, while deeper or widespread infections require oral treatment.
Cellulitis
Cellulitis rounds out the top 10, accounting for about 2% of skin-related disability. It’s a deeper bacterial infection of the skin and the tissue just beneath it, causing a spreading area of redness, warmth, swelling, and tenderness. It most often affects the lower legs and typically enters through a break in the skin, even one as minor as athlete’s foot or a small cut. Unlike surface infections, cellulitis can progress quickly and usually requires oral antibiotics. People with diabetes, obesity, or circulation problems in the legs are at higher risk for recurrent episodes.
Seborrheic Dermatitis and Rosacea
Two conditions that narrowly miss the global top 10 but are extremely common in daily practice deserve mention. Seborrheic dermatitis causes flaky, yellowish scales on the scalp (dandruff is its mildest form), eyebrows, and the creases beside the nose. It’s linked to an overgrowth of Malassezia yeast that naturally lives on the skin. Medicated shampoos containing antifungal agents are equally effective at controlling it, and twice-weekly use is the standard approach.
Rosacea affects the central face, causing persistent redness, visible blood vessels, and sometimes acne-like bumps. It has four recognized patterns: flushing and redness, bumps and pimples, skin thickening (especially on the nose), and eye involvement with dryness and irritation. Common triggers include temperature extremes, spicy food, alcohol, caffeine, stress, and sun exposure. Avoiding your personal triggers is the single most effective management strategy, while prescription creams can reduce redness and bumps during flares.
Vitiligo
Vitiligo causes smooth, white patches where the skin loses its pigment-producing cells. It affects 0.5% to 2% of people globally, including nearly 2 to 3 million adults in the U.S. The condition is autoimmune, meaning the body’s own immune cells attack and destroy the cells responsible for skin color. It can appear at any age but often starts before 30. Treatment traditionally relied on steroid creams and light therapy, but a newer class of topical medications that block the specific immune pathway destroying pigment cells has become available and shown meaningful repigmentation, particularly on the face.